Filter Results :

Your search for Pharmaceutical returned 23831 reports

Sort by


Germany Pharmaceuticals and Healthcare Report

08 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Germany's pharmaceutical and healthcare markets will continue to expand over the next tenyears, translating into renewed commercial opportunities for drugmakers operating in the country. Whilepatented medicines will continue to account for the largest share of the pharmaceutical market, ge...

$ 1,295.00

Read More

Hungary Pharmaceuticals and Healthcare Report

08 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Hungary's pharmaceuticals and healthcare market will remain a limited prospect forinvestment due to the systemic underfunding of the healthcare sector. While improvements to healthcareprovision and accessibility are likely to increase demand for medicines, the country's revenue earningoppo...

$ 1,295.00

Read More

Hong Kong Pharmaceuticals and Healthcare Report

08 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Hong Kong's FY2016/17 budget will be largely positive for the healthcare sector. Additionalresources have been committed to develop the administrative region's medical infrastructure, while fundingfor healthcare programmes and the elderly continue to grow. A key downside has been the reduc...

$ 1,295.00

Read More

Sri Lanka Pharmaceuticals and Healthcare Report

08 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Despite Sri Lanka's short-term fiscal challenges, the country's pharmaceutical and healthcaremarkets will continue to expand over the forecast period. In fact, under the FY2016 budget, the governmentoutlined the construction and upgrade of several healthcare facilities, which will broaden ...

$ 1,295.00

Read More

Nicaragua Pharmaceuticals and Healthcare Report

08 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Nicaragua will continue to be the least attractive pharmaceutical market in Central Americadue to limited healthcare funding, low per capita pharmaceutical expenditure, a substandard regulationsystem and socio-cultural preference for traditional medicines.Headline Expenditure ProjectionsPh...

$ 1,295.00

Read More

Microbiology Testing/Clinical Microbiology Market by Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), Clinical Application (Respiratory Diseases, STD, UTI), Product (instruments, Analyzers, Consumables) - Global Forecasts to 2021

03 Jun 2016  |  Published by:  MarketsandMarkets
The global clinical microbiology market is projected to reach USD 5.77 billion by 2021 from USD 3.35 billion in 2016, growing at a CAGR of 11.5%, during 2016 to 2021. Market growth can be attributed to factors such as the technological advancements; rising incidence of infectious diseases and ...

$ 5,650.00

Read More

In Vitro Toxicology Testing Market by Product, Type (ADME), Toxicity Endpoints & Tests (Carcinogenicity, Dermal Toxicity, Genotoxicity), Technology (Genomics, Transcriptomics), Method (Cellular Assays), Industry (Pharmaceutical) - Global Forecast to 2021

03 Jun 2016  |  Published by:  MarketsandMarkets
The global in vitro toxicology testing market is expected to USD 27.36 billion by 2021 from USD 14.15 billion in 2016, at a CAGR of 14.1% between 2016 and 2021. By product, the market includes assays, reagents & labware, and services. Based on toxicity endpoints & tests, the market is ...

$ 4,650.00

Read More

Ireland Pharmaceuticals and Healthcare Report

01 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The export-oriented Irish pharmaceutical industry will continue to benefit from its R&D andmanufacturing capabilities as well as its competitive business environment. While the new US federal ruleson so-called corporate inversion deals will mitigate purely tax-driven acquisitions of Ir...

$ 1,295.00

Read More

Moldova Pharmaceuticals and Healthcare Report

01 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Moldova's pharmaceutical market presents very limited opportunities for multinationaldrugmakers, in comparison to its neighbours in Eastern Europe. The country's small total market size andits reliance on out-of-pocket payments highlight the challenges it poses. Moreover, continued economi...

$ 1,295.00

Read More

Spectrum Pharmaceuticals Partnering Deals and Alliances 2010 to 2016

01 Jun 2016  |  Published by:  CurrentPartnering
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date d...

$ 1,495.00

Read More

Sun Pharmaceutical 2010 to 2016

01 Jun 2016  |  Published by:  CurrentPartnering
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date d...

$ 1,495.00

Read More

Namibia Pharmaceuticals and Healthcare Report

01 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: While Namibia's business environment is receptive to foreign investment, the country'srelatively small pharmaceutical market and below average per capita spending on medicines means thatmultinationals are instead drawn to other, more lucrative South African countries. As a result, Namibia ...

$ 1,295.00

Read More

Morocco Pharmaceuticals and Healthcare Report

01 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The Moroccan government's increasing efforts to improve healthcare coverage will be thelargest driver of pharmaceutical growth in the country over the coming years. Morocco has seen recentimprovements towards its regulatory standards; however, the government's long-term commitment to thisa...

$ 1,295.00

Read More

Bangladesh Pharmaceuticals and Healthcare Report

01 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Replicating India's success in the generic drugs sector will remain a challenge for Bangladesh.The country's strategy of leveraging upon an extension of the patent waiver for least developed countriespresents limited opportunities, as many of these markets have low levels of healthcare acc...

$ 1,295.00

Read More

Canada Pharmaceuticals and Healthcare Report

01 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Canada has a number of domestic pharmaceutical firms and is a major market for foreignbasedcompanies. Despite the expanding implementation of cost-containment reforms and rising uptake oflower cost generic drugs, the effects of these trends will be mitigated by rising demand for and consum...

$ 1,295.00

Read More
Total 23831 records.